Cardiovascular disease is the "first killer" of human beings, and heart failure is the terminal stage of heart disease development .SST2 can help man predict the classification, risk stratification and death of patients with heart failure. The determination of sST2 combined with the determination of BNP or NT-probNP can better improve the accuracy of heart failure prognosis judgment.
This product is used to quantitatively detect the concentration of sST2 in human serum, plasma or whole blood in vitro.